The Patent Finder

Fed-Batch Cell Culture Methods Using Non-Animal-Based Hydrolysates

AbbVie Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 60/845,158, filed Sep 13, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,663,945Methods of Producing Anti-TNF-alpha Antibodies in Mammalian Cell Culture
In force
 · High confidence
Abbott LaboratoriesIn force
High confidence
US 8,906,646Fed-Batch Method of Making Human Anti-TNF-Alpha Antibody
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 8,911,964Fed-Batch Method of Making Human Anti-TNF-Alpha Antibody
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,073,988Fed Batch Method of Making Anti-TNF-Alpha Antibodies
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,090,867Fed-Batch Method of Making Anti-TNF-alpha Antibody
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,234,032Fed-Batch Methods for Producing Adalimumab
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 9,284,371Methods of Producing Adalimumab
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 10,119,118A Modified Serum-Free Cell Culture Medium
In force
 · High confidence
AbbVie Inc.In force
High confidence
US 8,093,045Fed-Batch Cell Culture Methods Using Non-Animal-Based Hydrolysates
In force
 · High confidence
AbbVie Inc.In force
High confidence
Application 14/156,829Cell Culture Improvements
Abandoned
Abandoned Oct 3, 2015
AbbVie Inc.AbandonedAbandoned Oct 3, 2015
4 more patents in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 8 expiring within the 18 months from Nov 16, 2026.
Upgrade to Pro
8 of these are in force and held by AbbVie Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited